“…For example, many cancer types are characterized by decreased global methylation levels, except for promoter regions of crucial regulatory and tumor suppressor genes which are hypermethylated and their expression is therefore silenced ( Traube and Carell, 2017 ). Moreover, several neuroepigenetic changes have been recently described in neurodevelopmental, psychiatric and neurodegenerative disorders ( Cholewa-Waclaw et al, 2016 ), such as: autism ( Aspra et al, 2022 ), schizophrenia ( Song et al, 2022 ), posttraumatic stress disorder ( Montalvo-Ortiz et al, 2022 ), heroin addiction ( Kozlenkov et al, 2017 ), and Parkinson’s disease ( Kaut et al, 2022 ).…”